Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / LXRX - Citi lifts Lexicon Pharmaceutical price target to Street high

LXRX - Citi lifts Lexicon Pharmaceutical price target to Street high

Lexicon Pharmaceuticals Inc.
Citi analyst Yigai Nochomovitz raises the price target on Lexicon Pharmaceuticals (LXRX) to a Street high $13 from previous $7 PT and maintains Buy rating.LXRX stock doubled in regular trading on Thursday to close at $8.05 after the company cleared a key hurdle for partnership discussions regarding its potential heart failure treatment, sotagliflozin."We expect Lexicon's ongoing partnership discussions will accelerate on the heels of this news, as it was our understanding that some interested parties were waiting for regulatory clarity," writes Nochomovitz in a note to clients. "With that clarity now in hand, we believe a partnership for sota is imminent."LXRX shares slip 3.2% in after-hours trading after surging 106% in regular trading.See LXRX's price target history:

For further details see:

Citi lifts Lexicon Pharmaceutical price target to Street high
Stock Information
Company Name: Lexicon Pharmaceuticals Inc.
Stock Symbol: LXRX
Market: NASDAQ
Website: lexpharma.com
Menu
LXRX LXRX Quote LXRX Short LXRX News LXRX Articles LXRX Message Board
Get LXRX Alerts

News, Short Squeeze, Breakout and More Instantly...